Bioresorbable polymers, also referred to as biodegradable or bioabsorbable polymers, are polymer materials which can be safely absorbed by the body so that the materials from which a construction is made disappear over time. The Europe bioresorbable polymers is estimated at USD 612.46 million in 2016 and is projected to reach USD 1182.86 million by 2021 growing at CAGR of 14.07%.
One of the major factors driving the European bioresorbable polymers market is the increase in patient comfort brought about by bioresorbable polymers. In case of conventional materials, they are left in the body post-surgery which require another minor surgery to remove the materials, some presenting a health risks to the patient. Further, the growing demand for bioresorbable polymers for drug delivery is another key aspect boosting the growth of bioresorbable polymers market in European countries. The chemically neutral nature of bioresorbable polymers and their harmless decomposition in the body make them perfect for drug delivery.
However, due to employment of advanced technology, bioresorbable polymers cost more than conventional medical polymers which is limiting its reach to people Central and Eastern European countries along with the lack of advanced healthcare infrastructure.
The Europe bioresorbable market is segmented and analysed on the basis of type into Agro-polymers (Polysaccharides, Proteins) and Biopolyesters (polylactic acid, Polyglycolic Acid, Polycaprolactone and others). The most commonly used bioresorbable polymer is polylactic acid (PLA), also known as polylactide, and is made from a lactide monomer. Normally, polylactic acid (PLA) is the main building block for bioresorbable polymer materials. Further, on the basis of application the market is segregated under Orthopaedics, Drug Delivery and others. Geographically, the European Bioresorbable market is segmented in individual countries, namely United Kingdom, Spain, Germany, Spain and Italy.
Some of the key players operating in the European Bioresorbable market are Corbion Purac Inc., Evonik Industries AG, Foster Corporation, Koninklijke DSM N.V., Wright Medical Technology, Inc., and KLS Martin Group.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Agro-Polymers
5.1.1.1 Polysaccharides
5.1.1.2 Proteins
5.1.2 Biopolyesters
5.1.2.1 Polylactic Acid (PLA)
5.1.2.2 Polyglycolic Acid
5.1.2.3 Polycaprolactone
5.1.2.4 Others
5.2 By Application
5.2.1 Orthopedics
5.2.1.1 Trauma
5.2.1.2 Hip
5.2.1.3 Knee
5.2.1.4 Spine
5.2.1.5 Cranio Maxillofacial Surgery (CMS)
5.2.1.6 Others
5.2.2 Drug Delivery
5.2.2.1 Oral
5.2.2.2 Parenteral
5.2.2.3 Others
5.2.3 Others
6. Geographical Analysis
6.1 Introduction
6.2 United Kingdom
6.3 Germany
6.4 France
6.5 Spain
6.6 Italy
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Analysis of bioresorbable polymer production, Distribution Channel, Sales, Market Status (2016-2021)
8.1 Sales Overview
8.2 Supply Consumption & GAP of bioresorbable polymers
8.3 Import, Export & Bioresorbable Polymers
9. Market Leaders' Analysis
9.1 Corbion Purac,Inc.,
9.1.1 Overview
9.1.2 Product Analysis
9.1.3 Financial analysis
9.1.4 Recent Developments
9.1.5 SWOT analysis
9.1.6 Analyst View
9.2 Evonik Industries AG
9.3 Foster Corporation
9.4 KLS Martin Group
9.5 Koninklijke DSM N.V.
9.6 Wright Medical Technology, Inc
10. Competitive Landscape
10.1 Market share analysis
10.2 Merger and Acquisition Analysis
10.3 Agreements, collaborations and Joint Ventures
10.4 New Product Launches
11. Expert Opinions
11.1 Market Outlook
11.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
